Can fetal listeriosis lead to fetal growth restriction?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 17, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Can Fetal Listeriosis Cause Fetal Growth Restriction?

Yes, fetal listeriosis can cause fetal growth restriction, as infections are recognized as one of the pathological causes of FGR, though the primary mechanism appears to be acute placental invasion leading to fetal demise rather than chronic growth restriction. 1

Understanding the Mechanism

The most recent international guidelines explicitly identify infections as a cause of fetal growth restriction alongside placental insufficiency and genetic disorders 1. However, the clinical reality of listeriosis in pregnancy reveals a more nuanced picture:

Acute vs. Chronic Pathology

Listeria monocytogenes demonstrates preferential tropism for the maternal-fetal interface, with the highest bacterial burden found in fetal tissues, followed by decidua and placenta, and relatively lower burden in maternal organs 2. The pathophysiology involves:

  • Vascular pathology: Vasculitis, fibrinoid necrosis, and thrombosis of decidual spiral arteries
  • Placental infection: Acute chorioamnionitis and villitis
  • Direct fetal invasion: Hematogenous spread to the fetus 2

Clinical Presentation Pattern

The dominant clinical outcome of fetal listeriosis is rapid fetal demise rather than chronic growth restriction. Recent case reports demonstrate:

  • Intrauterine fetal death occurring within 8 hours of maternal symptom onset 3
  • Fetal death within 7-13 days of maternal exposure in primate models 2
  • High fetal mortality rate of 25-35% depending on gestational age 4

Clinical Implications

When to Suspect Listeriosis

In febrile pregnant patients, consider listeriosis when you observe:

  • Fetal tachycardia
  • Uterine contractions/activity
  • Marked inflammatory response (leukocytosis, neutrophilia, elevated CRP)
  • No alternative infection source identified 3
  • Abnormal amniotic fluid echogenicity 3

Critical Management Pitfall

Cephalosporins (including ceftriaxone) have NO activity against Listeria monocytogenes 3. This intrinsic resistance can delay effective treatment when listeriosis is not suspected.

Appropriate Antibiotic Coverage

  • First-line: Ampicillin or amoxicillin (alone or with gentamicin)
  • Alternative: Trimethoprim/sulfamethoxazole
  • These agents achieve high intracellular concentrations and cross the placenta 4

Gestational Age Considerations

First-trimester exposure poses greater risk than currently appreciated 2. While listeriosis is typically recognized in the third trimester, evidence from primate models demonstrates that first-trimester exposure consistently results in fetal demise within 7-13 days 2.

Prevention Counseling

Advise pregnant patients to avoid:

  • Refrigerated ready-to-eat foods (Listeria grows at refrigeration temperatures)
  • Raw seafood (including sushi) 5
  • Deli meats and soft cheeses
  • Long shelf-life products 4

Bottom Line for Clinical Practice

While infections including listeriosis are formally recognized as causes of FGR in current guidelines 1, the acute and severe nature of fetal listeriosis means that affected fetuses typically experience rapid demise rather than chronic growth restriction. The maternal immune response that protects the mother from severe disease cannot protect the fetus 2, making early recognition and appropriate antibiotic therapy essential to prevent fetal loss rather than to manage growth restriction.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.